The Nottingham Proceedings (Current Controversies in the Treatment of Breast Cancer, Vol. 2)

This book reviews recent developments in the use of chemotherapy for breast cancer, examining newly developed drugs, relative risks for patients and a range of prognoses. The chapters include contributions on Zoladex therapy for carcinoma of the breast, systemic adjuvant therapy following treatment for primary breast cancer, the future of endocrine agents, the use of tamoxifen in chemotherapy, prognosis of various cancers and the results of British and German clinical trials.